ptosis after transfection into MCF-7 cells (Vincenz and
Dixit, 1997), but its physiological role is unknown. Moreover, the participation of individual caspases in abnormalities of lymphocyte homeostasis and autoimmunity has not been defined.
Since the initial description of defective lymphocyte apoptosis associated with Fas mutations, we have examined 68 kindreds affected with various autoimmune and lymphoproliferative abnormalities, most of which prove to be ALPS type 1a. Here, we describe two ALPS type II families with autoimmunity and pleiotropic apoptosis defects in multiple pathways, but no molecular abnormalities in Fas, FasL, TNFR1, TNFR2, FADD, or CASP8. Rather, we found distinct inherited amino acid substitutions in CASP10 in each family that resulted in decreased enzyme activity and diminished apoptosis by multiple death receptors. In contrast to Fas mutations leading to ALPS type I, these CASP10 defects underlie a unique disorder of dendritic cell and lymphocyte homeostasis.
Results

Clinical Features
The proband in family 11 is an 11-year-old African American female first evaluated at the NIH in 1992. At one year of age, she developed prominent nonmalignant ad- 
. We also examined apoptosis rehomeostasis. Also, 42% of her peripheral lymphocytes sponses to a trimeric form of the TRAIL death-inducing were the normally rare (Ͻ1%) CD4 Ϫ CD8 Ϫ ␣␤ T cells, ligand (Walczak et al., 1999) and found defects in Pt 11 which are increased in ALPS type I and in murine lpr and her mother's lymphocytes, but not in ALPS type I disease but usually not to this degree. The patient's patients ( Figure 1 and data not shown). No apoptosis mother exhibited high levels of autoantibodies to nudefects were found in the father and sisters of Pt 11 clear antigens and defective lymphocyte apoptosis (see (Figure 1 ). Pt 36 also exhibited abnormal apoptosis rebelow), both of which are features of ALPS. The patient's sponses to TCR, Fas, or TRAIL stimulation, while his father and two sisters are healthy. parents exhibited modest but significant defects. Flow The proband of family 36 is a 10-year-old Ashkenazi cytometry showed that Fas expression as well as apoJewish male recently evaluated at the NIH. Adenopathy ptosis in response to staurosporine or lymphokine withbegan at 11 months followed by bouts of prolonged drawal was normal in Pt 11 and Pt 36 (data not shown). fever, splenomegaly, elevated sedimentation rate, aneThese data suggested that Pt 11 might have inherited mia, and reticulocytosis. At age 3, he had noninfectious, a novel selective apoptosis defect from her mother in a lymphocytic meningitis followed by optic neuritis indiheterozygous dominant fashion. By contrast, a putative cating a pattern of disparate inflammatory conditions. genetic defect in Pt 36 would either have homozygous At his recent evaluation, he exhibited adenopathy and inheritance or have arisen de novo. Moreover, the aposplenomegaly. Autoantibodies were not detected, but ptosis defects in these families, unlike that in ALPS type lymphocyte phenotyping showed a dramatic T and B (Fisher et al., 1995) . We therefore examined apoptosis in activated peripheral blood 11 that was a C to T transition predicted to replace a leucine by phenylalanine in the p17 subunit of the protedownstream of the QACQG active site in the p17 subunit of the CASP10 gene ( Figure 2B ). This mutation occurred ase (Figure 2 and data not shown). In addition to the previously described CASP10 cDNA (Fernandes-Alnemri in cDNAs of both isoforms of CASP10. In contrast to Pt 11, no wild-type allele was detected in Pt 36, suggesting et al., 1996), we also detected a longer cDNA isoform (CASP10 L ). The CASP10 L isoform encoded an insertion that the mutant allele is homozygous ( Figure 2B ). This was confirmed by genomic DNA sequencing ( Figure 2B ). of 43 amino acids at the end of the prodomain identical to the prodomain of FLICE2, but its C terminus was the Examination of the genomic DNA of both parents revealed that each was heterozygous for the mutant allele, same as the short CASP10 isoform (Vincenz and Dixit, 1997). The two isoforms were expressed equally. Apindicating that the child had indeed inherited a mutant CASP10 allele from each parent. No other nucleotide proximately 50% of CASP10 cDNAs (of either isoform) were mutant, implying heterozygosity. This was conchanges were found in the CASP10 gene in Pt 36 or his parents. firmed by direct sequencing of genomic DNA, which revealed the wild-type C and mutant T nucleotides at To rule out the possibility that the mutations in Pt 11 and Pt 36 represented common genetic polymorphisms, the same position (Figure 2A ). Genomic DNA sequencing in the parents revealed that the father of Pt 11 and two we analyzed their frequency in the general population and determined their effects on caspase function. The sisters carried only wild-type alleles, but her mother harbored both mutant and wild-type alleles ( Figure 2A Pt 11 mutation destroyed a Stu I restriction site which we used to determine that 100 unrelated normal donor and data not shown). Thus, the mutant CASP10 allele in Pt 11 was inherited from her mother. No other base DNA samples, comprising 200 chromosomes, did not harbor this nucleotide change (data not shown). SSCP change in the coding or splicing sequences of CASP10 was found.
analysis did not detect the Pt 36 mutation in 120 genomic DNA samples (240 alleles) from healthy unrelated conIn Pt 36, SSCP screening followed by sequencing of cDNA clones revealed a G to A transition predicted to trols of varied ethnicity and 100 unrelated Ashkenazi Jewish genomic DNA samples (200 alleles) (data not cause a valine to isoleucine change seven amino acids shown). The CASP10 mutations have not been found in Quantitative analysis was performed with the bacterially expressed CASP10 protease domain of Pt 11 fused any ALPS type I patient or family member. Our screening did uncover one common polymorphic variant of CASP10 to glutathione S-transferase (GST). The wild-type CASP10 efficiently cleaved DEVD-AMC and to a lesser extent (nucleotide A1208→G in the p12 subunit), which was observed in 5% of normal controls and had no effect YVAD-MCA, but the Pt 11 mutant protein failed to do on apoptotic function of CASP10 (data not shown). so ( Figure 4A ). We also examined autoprocessing and Therefore, the CASP10 mutations in families 11 and 36 found that the wild-type 55 kDa GST fusion protein was are not common genetic polymorphisms.
cleaved to the 43 kDa active form by 15 min, whereas the mutant protein showed only 50% cleavage at 3 hr ( Figure 4B ). To distinguish between decreased intrinsic Abrogation of Apoptosis Activities catalytic ability versus the failure of the mutant protein by CASP10 Mutations to be recognized as an autosubstrate, equivalent amounts The cooccurrence of CASP10 mutations with apoptosis of cleaved wild-type and mutant GST-CASP10 were asdefects and immunological abnormalities in Pt 11 and sayed using a DEVD peptide substrate ( Figure 4C ). We Pt 36 suggested, but did not prove, that the mutations observed significantly reduced catalytic activity by the contributed to these abnormalities. We therefore determutant enzyme, with a K m of 709 Ϯ 14.4 M compared mined whether the altered forms of CASP10 were functo a K m of 71 Ϯ 12.9 M for the wild-type CASP10. tionally defective. Expression constructs of both the long and short isoforms of the wild-type or the CASP10 mutants were transfected into HeLa or MCF-7 cells toDominant-Negative Interaction gether with a ␤-gal reporter construct. The cells were of the Mutated CASP10 stained with X-gal, and cell death was assessed in the To explore how the heterozygous allele in Pt 11 and her blue transfected cells (Figure 3) . Either isoform of wildmother could impair apoptosis, we coexpressed Fas type CASP10 induced significant cell death, but neither with either the long or short isoform of the Pt 11 mutant isoform of the Pt 11 had detectable apoptotic activity CASP10 in 293 cells and found that apoptosis was supin this assay ( Figures 3A and 3B ). Similar analyses of the pressed ( Figure 5 ). We also coexpressed the CASP10 Pt 36 CASP10 revealed a significant, albeit less severe, defect in apoptosis function ( Figures 3A and 3C) . mutants with the TNFR1, DR3, DR4 (TRAIL-R1), and DR5 staurosporine (data not shown). Hence, the abnormal CASP10 protein specifically interfered with multiple death receptor pathways and not other apoptosis pathways.
To explain the interference in death pathways caused by the heterozygous CASP10 mutation in Pt 11, we hypothesized that CASP10 might be recruited into deathinducing signaling complexes (DISCs) with the cytoplasmic tails of death receptors. Because the prodomain of CASP10 is structurally similar to that of CASP8, it is possible that the mutant CASP10 can be recruited along with wild-type CASP8 or CASP10 into the DISC. We first tested the interactions of CASP10 with CASP8 or FADD using the yeast two-hybrid system and found that the long and short isoforms of either full-length CASP10 or the CASP10 DEDs interact with both CASP8 and FADD (data not shown). To directly test recruitment of Pt 11 mutant CASP10 into the DISC, we cotransfected Fas, FADD, and both isoforms of mutant CASP10 into 293T cells. Both FADD and the mutant CASP10 were readily detected in coprecipitates with Fas, consistent with previous observations on FLICE2 ( Figure 6 ; Vincenz and Dixit, 1997). Importantly, the mutant CASP10 isoforms are corecruited with endogenous CASP8 (Figure 6 , bottom). This suggests the possibility that the mutant CASP10 from Pt 11, which inefficiently autoprocesses, is recruited into the DISC together with CASP8 and could thereby block caspase activation in a dominant fashion.
Resistance of Dendritic Cells to TRAIL-Mediated Apoptosis
To explain the multiple autoimmune and inflammatory disorders in ALPS type II, we also examined how the Pt 11 and Pt 36 CASP10 mutations affect death receptorassociated apoptosis in antigen-presenting cells. Previous observations of T cell-dependent turnover of dendritic cells suggested that dendritic cells may undergo apoptosis triggered by death receptors (Ingulli et al., 1997). Dendritic cells were derived from peripheral blood using a previously described procedure (Sallusto and Lanzavecchia, 1994), and we first asked whether activated T cells could foster their death in vitro. Using 
, 1996). This amino acid change may have and Dixit, 1997). We found that the CASP10 mutations its functional effect by virtue of its proximity to the catain Pt 11 and Pt 36 impair Fas-mediated apoptosis in
lytic site rather than causing a global change in the p17 lymphocytes and TRAIL-induced killing in both lymphostructure. For Pt 11, the model suggests that Leu-242 cytes and dendritic cells. Moreover, transfection of the is equivalent to Leu-164 in the first ␤ strand of CASP3. severely defective Pt 11 CASP10 curtailed apoptosis This position is not near the substrate-binding pocket induction by Fas, TNFR1, DR3, DR4, and DR5. This sugbut at an internal location of the p17 subunit. The relagests that CASP10 affects a signal integration point for tively conservative nature of substitution of Phe for Leu apoptosis receptors. The downstream position of its (i.e., both are hydrophobic) and the fact that enzymatic effect at a point common to multiple cell death pathways activity is not completely abolished make it unlikely that could account for the severe pleiotropic autoimmunity the mutant p17 subunit is completely unfolded. Also, and inflammatory disorders and abnormal cellular hoLeu-242 is not sufficiently close to the interface of the meostasis in these two patients with ALPS type II. large and small subunits or the aspartates that are The signaling role of CASP10 vis-à -vis its close homocleaved during maturational processing to suggest that log CASP8 is not understood. The CASP8 and CASP10 it has a direct effect on processing or assembly. Rather, genes appear to be part of a gene duplication event in we favor the notion that there is a local perturbation of the human CASP8/10/c-FLIP locus (2q33, interval 204.7-the ␤ strand containing Leu-242. This strand directly 205.4). It is now evident that CASP10 in its mutant form connects to the P1 loop that contains Arg-179, which impairs apoptosis in the presence of a normal CASP8 plays a crucial role in catalysis by stabilizing the P1 gene. by TRAIL was calculated as described (Fisher et al., 1995) . mutation is a G to A mutation that occurs at a CpG dinucleotide, which is a known "hot spot" for C to T 
TRAIL. Similar lines of evidence indicate that this regulatory pathway is unimpaired by Fas mutations in ALPS
